153 related articles for article (PubMed ID: 32395802)
1. Is imagery distinctive in papillary renal cell carcinoma subtypes?
Karray O; Ayed H; Saadi A; Zaghbib S; Henchir S; Cherif A; Ben Miled A; Chakroun M; Bouzouita A; Derouiche A; Ben Slama R; Chebil M
Tunis Med; 2020 Feb; 98(2):131-137. PubMed ID: 32395802
[TBL] [Abstract][Full Text] [Related]
2. [Papillary renal cell carcinoma: clinic and pathological study about 27 cases].
Gargouri MM; Bargaoui W; Kallel Y; Nouira Y
Tunis Med; 2015 Jun; 93(6):381-5. PubMed ID: 26644102
[TBL] [Abstract][Full Text] [Related]
3. Prognostic implications of the magnetic resonance imaging appearance in papillary renal cell carcinoma.
Rosenkrantz AB; Sekhar A; Genega EM; Melamed J; Babb JS; Patel AD; Lo A; Najarian RM; Ahmed M; Pedrosa I
Eur Radiol; 2013 Feb; 23(2):579-87. PubMed ID: 22903703
[TBL] [Abstract][Full Text] [Related]
4. Histologic subtype needs to be considered after partial nephrectomy in patients with pathologic T1a renal cell carcinoma: papillary vs. clear cell renal cell carcinoma.
Yoo S; You D; Jeong IG; Song C; Hong B; Hong JH; Ahn H; Kim CS
J Cancer Res Clin Oncol; 2017 Sep; 143(9):1845-1851. PubMed ID: 28451753
[TBL] [Abstract][Full Text] [Related]
5. Renal cell carcinoma in the solitary kidney: an analysis of complications and outcome after nephron sparing surgery.
Ghavamian R; Cheville JC; Lohse CM; Weaver AL; Zincke H; Blute ML
J Urol; 2002 Aug; 168(2):454-9. PubMed ID: 12131287
[TBL] [Abstract][Full Text] [Related]
6. Survival analysis of 130 patients with papillary renal cell carcinoma: prognostic utility of type 1 and type 2 subclassification.
Pignot G; Elie C; Conquy S; Vieillefond A; Flam T; Zerbib M; Debré B; Amsellem-Ouazana D
Urology; 2007 Feb; 69(2):230-5. PubMed ID: 17275070
[TBL] [Abstract][Full Text] [Related]
7. The VENUSS prognostic model to predict disease recurrence following surgery for non-metastatic papillary renal cell carcinoma: development and evaluation using the ASSURE prospective clinical trial cohort.
Klatte T; Gallagher KM; Afferi L; Volpe A; Kroeger N; Ribback S; McNeill A; Riddick ACP; Armitage JN; 'Aho TF; Eisen T; Fife K; Bex A; Pantuck AJ; Stewart GD
BMC Med; 2019 Oct; 17(1):182. PubMed ID: 31578141
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors for the survival of patients with papillary renal cell carcinoma after surgical management.
Ren W; Gao X; Zhang X; Hu J; Li H; Zu X
Clin Transl Oncol; 2020 May; 22(5):725-733. PubMed ID: 31317521
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors for the survival of patients with papillary renal cell carcinoma: meaning of histological typing and multifocality.
Mejean A; Hopirtean V; Bazin JP; Larousserie F; Benoit H; Chrétien Y; Thiounn N; Dufour B
J Urol; 2003 Sep; 170(3):764-7. PubMed ID: 12913693
[TBL] [Abstract][Full Text] [Related]
10. High proliferation rate and TNM stage but not histomorphological subtype are independent prognostic markers for overall survival in papillary renal cell carcinoma.
Polifka I; Agaimy A; Herrmann E; Spath V; Trojan L; Stöckle M; Becker F; Ströbel P; Wülfing C; Schrader AJ; Barth P; Staehler M; Stief C; Hohenfellner M; Macher-Göppinger S; Wullich B; Noldus J; Brenner W; Roos FC; Walter B; Otto W; Burger M; Höfler H; Haferkamp A; Geppert CI; Stöhr C; Hartmann A;
Hum Pathol; 2019 Jan; 83():212-223. PubMed ID: 30121370
[TBL] [Abstract][Full Text] [Related]
11. Positive surgical margin following radical nephrectomy is an independent predictor of local recurrence and disease-specific survival.
Abu-Ghanem Y; Ramon J; Berger R; Kaver I; Fridman E; Leibowitz-Amit R; Dotan ZA
World J Surg Oncol; 2017 Nov; 15(1):193. PubMed ID: 29096642
[TBL] [Abstract][Full Text] [Related]
12. [Clinicopathological features and prognostic analysis of papillary renal cell carcinoma].
Bo ES; Hong P; Zhang Y; Deng SH; Ge LY; Lu M; Li N; Ma LL; Zhang SD
Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Aug; 54(4):615-620. PubMed ID: 35950382
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of perinephric fat infiltration and tumor size in renal cell carcinoma.
Yoo C; Song C; Hong JH; Kim CS; Ahn H
J Urol; 2008 Aug; 180(2):486-91; discussion 491. PubMed ID: 18550101
[TBL] [Abstract][Full Text] [Related]
14. Nephron-sparing surgery for renal cell carcinoma: clinicopathologic features predictive of patient outcome.
Krejci KG; Blute ML; Cheville JC; Sebo TJ; Lohse CM; Zincke H
Urology; 2003 Oct; 62(4):641-6. PubMed ID: 14550434
[TBL] [Abstract][Full Text] [Related]
15. The subclassification of papillary renal cell carcinoma does not affect oncological outcomes after nephron sparing surgery.
Bigot P; Bernhard JC; Gill IS; Vuong NS; Verhoest G; Flamand V; Reix B; Suer E; Gökce I; Beauval JB; Nouhaud FX; Eto M; Baco E; Matsugasumi T; Chowaniec Y; Rigaud J; Lenormand C; Pfister C; Hetet JF; Ploussard G; Roupret M; Léon P; Bakri AE; Larré S; Tillou X; Doerfler A; Descazeaud A; Koutlidis N; Schneider A; Sebe P; Ingels A; Azzouzi AR; Soulié M; Méjean A; Bensalah K; Patard JJ;
World J Urol; 2016 Mar; 34(3):347-52. PubMed ID: 26149352
[TBL] [Abstract][Full Text] [Related]
16. Tumor Enhancement on Dynamic CT: A Predictive Factor for Recurrence After Nephrectomy in Localized T1 Clear Cell Renal Cell Carcinoma.
Maehara J; Nishie A; Asayama Y; Ishigami K; Ushijima Y; Takayama Y; Okamoto D; Fujita N; Sugimoto M; Inokuchi J; Honda H
Anticancer Res; 2018 Apr; 38(4):2377-2383. PubMed ID: 29599364
[TBL] [Abstract][Full Text] [Related]
17. Impact of histologic subtype and sarcomatoid transformation on metastasis in renal cell carcinoma: a single institute experience in 149 patients.
Tirumani SH; Souza D; Krajewski KM; Jagannathan JP; Ramaiya NH; Shinagare AB
Abdom Radiol (NY); 2016 Feb; 41(2):295-302. PubMed ID: 26867911
[TBL] [Abstract][Full Text] [Related]
18. [Incidence and long-term prognosis of papillary renal cancer. Results of a retrospective multicenter study].
Waalkes S; Roos FC; Eggers H; Schumacher S; Janssen M; Wegener G; Thüroff JW; Hofmann R; Schrader M; Kuczyk MA; Schrader AJ;
Urologe A; 2011 Sep; 50(9):1125-9. PubMed ID: 21845424
[TBL] [Abstract][Full Text] [Related]
19. Analysis of clinicopathologic predictors of oncologic outcome provides insight into the natural history of surgically managed papillary renal cell carcinoma.
Margulis V; Tamboli P; Matin SF; Swanson DA; Wood CG
Cancer; 2008 Apr; 112(7):1480-8. PubMed ID: 18240184
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for locoregional relapse after radical nephrectomy.
Jhavar S; Swanson G; Pruszynski J
Asia Pac J Clin Oncol; 2018 Jun; 14(3):192-197. PubMed ID: 28488392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
